“…Previous studies have demonstrated that SMILE is safe and effective for the correction of myopia and myopic astigmatism (Sekundo et al 2008(Sekundo et al , 2011(Sekundo et al , 2014Blum et al 2010a,b;Shah & Shah 2011b;Shah et al 2011a;Hjortdal et al 2012;Kamiya et al 2012Kamiya et al , 2014Vestergaard et al 2012;Ganesh & Gupta 2014;Lin et al 2014;Xu & Yang 2015). Early visual and refractive outcomes of SMILE are desirable, but the postoperative follow-up period in most studies only spans 3-12 months (Sekundo et al 2008(Sekundo et al , 2011(Sekundo et al , 2014Blum et al 2010a,b;Shah & Shah 2011b;Shah et al 2011a;Hjortdal et al 2012;Kamiya et al 2012Kamiya et al , 2014Kamiya et al , 2015Vestergaard et al 2012;A gca et al 2014;Ganesh & Gupta 2014;Lin et al 2014;Reinstein et al 2014;Kunert et al 2015;Xu & Yang 2015), with the exception of one study with a 2-years follow-up (Yıldırım et al 2016), two with a 3-years follow-up (Pedersen et al 2015;Messerschmidt-Roth et al 2016), and one with a 5-years follow-up (Blum et al 2016). Our primary hypothesis is that SMILE seems to exceed LASIK in terms of its refractive stability and predictability.…”